These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
48. Emphysema assessment for personalized immunotherapy response prediction in lung cancer patients. Kerdidani D; Magkouta S; Tsoumakidou M J Thorac Dis; 2019 Sep; 11(Suppl 15):S2034-S2035. PubMed ID: 31632820 [No Abstract] [Full Text] [Related]
49. Immunoescape the link between emphysema and lung cancer? Sauleda J; Verdú FJ; Scrimini S; Sala E; Pons J J Thorac Dis; 2019 Mar; 11(Suppl 3):S329-S330. PubMed ID: 30997211 [No Abstract] [Full Text] [Related]
50. ERS/ESTS/ESTRO/ESR/ESTI/EFOMP statement on management of incidental findings from low dose CT screening for lung cancer. O'Dowd EL; Tietzova I; Bartlett E; Devaraj A; Biederer J; Brambilla M; Brunelli A; Chorostowska J; Decaluwe H; Deruysscher D; De Wever W; Donoghue M; Fabre A; Gaga M; van Geffen W; Hardavella G; Kauczor HU; Kerpel-Fronius A; van Meerbeeck J; Nagavci B; Nestle U; Novoa N; Prosch H; Prokop M; Putora PM; Rawlinson J; Revel MP; Snoeckx A; Veronesi G; Vliegenthart R; Weckbach S; Blum TG; Baldwin DR Eur J Cardiothorac Surg; 2023 Oct; 64(4):. PubMed ID: 37804174 [TBL] [Abstract][Full Text] [Related]
51. Association between the number and size of intrapulmonary lymph nodes and chronic obstructive pulmonary disease severity. Schreuder A; Jacobs C; Scholten ET; Prokop M; van Ginneken B; Lynch DA; Schaefer-Prokop CM; PeerJ; 2020; 8():e9166. PubMed ID: 32685283 [TBL] [Abstract][Full Text] [Related]
52. Emphysema quantification using low-dose computed tomography with deep learning-based kernel conversion comparison. Bak SH; Kim JH; Jin H; Kwon SO; Kim B; Cha YK; Kim WJ Eur Radiol; 2020 Dec; 30(12):6779-6787. PubMed ID: 32601950 [TBL] [Abstract][Full Text] [Related]
53. Technical Note: Design and implementation of a high-throughput pipeline for reconstruction and quantitative analysis of CT image data. Hoffman J; Emaminejad N; Wahi-Anwar M; Kim GH; Brown M; Young S; McNitt-Gray M Med Phys; 2019 May; 46(5):2310-2322. PubMed ID: 30677145 [TBL] [Abstract][Full Text] [Related]
54. Predicting all-cause and lung cancer mortality using emphysema score progression rate between baseline and follow-up chest CT images: A comparison of risk model performances. Schreuder A; Jacobs C; Gallardo-Estrella L; Prokop M; Schaefer-Prokop CM; van Ginneken B PLoS One; 2019; 14(2):e0212756. PubMed ID: 30789954 [TBL] [Abstract][Full Text] [Related]
55. Relationship and prognostic value of modified coronary artery calcium score, FEV1, and emphysema in lung cancer screening population: the MILD trial. Sverzellati N; Cademartiri F; Bravi F; Martini C; Gira FA; Maffei E; Marchianò A; La Vecchia C; De Filippo M; Kuhnigk JM; Rossi C; Pastorino U Radiology; 2012 Feb; 262(2):460-7. PubMed ID: 22114241 [TBL] [Abstract][Full Text] [Related]
56. Severity of emphysema predicts location of lung cancer and 5-y survival of patients with stage I non-small cell lung cancer. Bishawi M; Moore W; Bilfinger T J Surg Res; 2013 Sep; 184(1):1-5. PubMed ID: 23810745 [TBL] [Abstract][Full Text] [Related]
57. Identification of chronic obstructive pulmonary disease in lung cancer screening computed tomographic scans. Mets OM; Buckens CF; Zanen P; Isgum I; van Ginneken B; Prokop M; Gietema HA; Lammers JW; Vliegenthart R; Oudkerk M; van Klaveren RJ; de Koning HJ; Mali WP; de Jong PA JAMA; 2011 Oct; 306(16):1775-81. PubMed ID: 22028353 [TBL] [Abstract][Full Text] [Related]
58. Normalized emphysema scores on low dose CT: Validation as an imaging biomarker for mortality. Gallardo-Estrella L; Pompe E; de Jong PA; Jacobs C; van Rikxoort EM; Prokop M; Sánchez CI; van Ginneken B PLoS One; 2017; 12(12):e0188902. PubMed ID: 29227997 [TBL] [Abstract][Full Text] [Related]